-+ 0.00%
-+ 0.00%
-+ 0.00%

PRESS RELEASE: SANOFI’S MENQUADFI APPROVED IN THE EU FOR USE IN INFANTS FROM AGE SIX WEEKS AGAINST INVASIVE MENINGOCOCCAL DISEASE

Reuters·08/04/2026 05:00:10

Please log in to view news